PDIA4 and diabetes mellitus: We conceptualized these findings as follows: under pathological conditions, excessive Pdia4 and ROS led to β‐cell failure and diabetes; conversely, Pdia4 ablation and inhibition diminished ROS content in β‐cells and, thereby, reduced β‐cell failure and diabetes development.